Mezavant is available as 1200mg gastro-resistant prolonged-release tablets. The recommended dose for induction of remission is two to four tablets taken once daily with food.
The highest dose of four tablets daily is recommended for patients not responding to lower doses of mesalazine. When using the highest dose, the effect of the treatment should be evaluated at eight weeks.
The recommended dose for maintenance of remission is two tablets taken once daily.
Further information: Shire 01256 894000